Literature DB >> 31812787

Identification of a hormone response element that mediates suppression of APOF by LXR and PPARα agonists.

Yan Liu1, Lahoucine Izem1, Richard E Morton2.   

Abstract

Apolipoprotein F (ApoF) regulates cholesteryl ester transfer protein activity. We previously observed that hepatic APOF mRNA levels are decreased by high fat, cholesterol-enriched diets. Here we show in human liver C3A cells that APOF mRNA levels are reduced by agonists of LXR and PPARα nuclear receptors. This negative regulation requires co-incubation with the RXR agonist, retinoic acid. Bioinformatic analysis of the ~2 kb sequence upstream of the APOF promoter identified one potential LXR and 4 potential PPARα binding sites clustered between nucleotides -2007 and -1961. ChIP analysis confirmed agonist-dependent binding of LXRα, PPARα, and RXRα to this hormone response element complex (HREc). A luciferase reporter containing the 2 kb 5' APOF sequence was negatively regulated by LXR and PPARα ligands as seen in cells. This regulation was maintained in constructs lacking the ~1700 nucleotides between the HREc and the APOF proximal promoter. Mutations of the HREc that disrupted LXRα and PPARα binding led to the loss of reporter construct inhibition by agonists of these nuclear receptors. siRNA knockdown studies showed that APOF gene regulation by LXRα or PPARα agonists did not require an interaction between these two nuclear receptors. Thus, APOF is subject to negative regulation by agonist-activated LXR or PPARα nuclear receptors binding to a regulatory element ~1900 bases 5' to the APOF promoter. High fat, cholesterol-enriched diets likely reduce APOF gene expression via these receptors interacting at this regulatory site.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apolipoprotein F; Apolipoproteins; Cholesteryl ester transfer protein; Gene expression; Nuclear receptors/lipid ligands; Transcription

Mesh:

Substances:

Year:  2019        PMID: 31812787      PMCID: PMC6957717          DOI: 10.1016/j.bbalip.2019.158583

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  43 in total

1.  Transcriptional regulation of the apolipoprotein F (ApoF) gene by ETS and C/EBPα in hepatoma cells.

Authors:  Xue-Bin Shen; Ling Huang; Shao-Hong Zhang; De-Ping Wang; Yun-Li Wu; Wan-Nan Chen; Shang-Hua Xu; Xu Lin
Journal:  Biochimie       Date:  2015-02-26       Impact factor: 4.079

2.  Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha.

Authors:  T A Spencer; D Li; J S Russel; J L Collins; R K Bledsoe; T G Consler; L B Moore; C M Galardi; D D McKee; J T Moore; M A Watson; D J Parks; M H Lambert; T M Willson
Journal:  J Med Chem       Date:  2001-03-15       Impact factor: 7.446

3.  ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters.

Authors:  Richard E Morton; Yan Liu; Lahoucine Izem
Journal:  J Lipid Res       Date:  2019-09-11       Impact factor: 5.922

4.  Novel aspects of PPARalpha-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study.

Authors:  Pascal G P Martin; Hervé Guillou; Frédéric Lasserre; Sébastien Déjean; Annaig Lan; Jean-Marc Pascussi; Magali Sancristobal; Philippe Legrand; Philippe Besse; Thierry Pineau
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

5.  Human SREBP1c expression in liver is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha).

Authors:  Ana Fernández-Alvarez; María Soledad Alvarez; Raúl Gonzalez; Carme Cucarella; Jordi Muntané; Marta Casado
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

6.  Farnesoid X receptor up-regulates expression of lipid transfer inhibitor protein in liver cells and mice.

Authors:  Liangpeng Li; Hong Liu; Jiahe Peng; Yongchao Wang; Yan Zhang; Jinyu Dong; Xiaohua Liu; Dongmei Guo; Yu Jiang
Journal:  Biochem Biophys Res Commun       Date:  2013-11-06       Impact factor: 3.575

7.  Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor.

Authors:  Elaine M Quinet; Dawn A Savio; Anita R Halpern; Liang Chen; Christopher P Miller; Ponnal Nambi
Journal:  J Lipid Res       Date:  2004-08-01       Impact factor: 5.922

8.  Peroxisome proliferator-activated receptor alpha target genes.

Authors:  Maryam Rakhshandehroo; Bianca Knoch; Michael Müller; Sander Kersten
Journal:  PPAR Res       Date:  2010-09-26       Impact factor: 4.964

9.  Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2.

Authors:  Julie R Secor McVoy; Hanadi Ajam Oughli; Unsong Oh
Journal:  J Neuroinflammation       Date:  2015-02-10       Impact factor: 8.322

10.  Effect of synthetic dietary triglycerides: a novel research paradigm for nutrigenomics.

Authors:  Linda M Sanderson; Philip J de Groot; Guido J E J Hooiveld; Arjen Koppen; Eric Kalkhoven; Michael Müller; Sander Kersten
Journal:  PLoS One       Date:  2008-02-27       Impact factor: 3.240

View more
  3 in total

1.  Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism.

Authors:  Yan Liu; Richard E Morton
Journal:  Curr Opin Lipidol       Date:  2020-08       Impact factor: 4.776

Review 2.  The Roles of Fatty Acids and Apolipoproteins in the Kidneys.

Authors:  Xiaoyue Pan
Journal:  Metabolites       Date:  2022-05-20

3.  Both full length-cholesteryl ester transfer protein and exon 9-deleted cholesteryl ester transfer protein promote triacylglycerol storage in cultured hepatocytes.

Authors:  Yan Liu; Daniel Mihna; Lahoucine Izem; Richard E Morton
Journal:  Lipids       Date:  2021-12-05       Impact factor: 1.646

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.